Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


HIV Medication
Jan 9, 2014

If CD$ is 565 should i start medication now

Response from Dr. Young

Hi and thanks for posting.

Current US treatment guidelines recommend treatment for all people living with HIV who are willing, and able to be adherent to treatment. To quote, " Antiretroviral therapy (ART) is recommended for all HIV-infected individuals to reduce the risk of disease progression." (If you live outside of the US, the World Health Organization now recommends treatment when CD4 counts are below 500.)

If you were my patient, I'd garner all the needed baseline laboratory and clinical assessments and make an individualized decision about when, and what treatments to start.

Hope that helps, BY



Previous
TOPVEIN HERBAL AIDS CURE
Next
How long does it take for Truvada PrEP to be fully saturated and working?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement